3-Bromo-2-methoxypyridine hydrochloride

Catalog No.: 
ACWWWM422
CAS No.: 
13472-88-3
Molecular Formula: 
C6H7BrClNO
Molecular Weight: 
224.49
3-Bromo-2-methoxypyridine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$98.00InquiryInquiry
25g95%$480.00InquiryInquiry
100g95%$1901.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-2-methoxypyridine hydrochloride
IUPAC Name3-bromo-2-methoxypyridine hydrochloride
MDL No.MFCD28048565
Molecular FormulaC6H7BrClNO
Molecular Weight224.49
SMILESCOC1=NC=CC=C1Br.[H]Cl
InChI KeyOVGXQBBFWXEGGQ-UHFFFAOYSA-N
CAS No.13472-88-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACWWWM422 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACHTRE764 route compound structure diagram
    ACHTRE76452200-48-3In Stock
  4. Then
  5. ACWWWM422 route product structure diagram
    ACWWWM42213472-88-3
Inquiry

2. ACWWWM422 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACHTRE764 route compound structure diagram
    ACHTRE76452200-48-3In Stock
  4. Then
  5. ACWWWM422 route product structure diagram
    ACWWWM42213472-88-3
Inquiry

3. ACWWWM422 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDETX276 route compound structure diagram
    ACDETX27613466-43-8In Stock
  4. Then
  5. ACWWWM422 route product structure diagram
    ACWWWM42213472-88-3
Inquiry

Comments (0)